Navigation Links
Challenges and promise of cell-based therapies
Date:4/1/2008

What: Challenges and Promise of Cell-Based Therapies is a one-day symposium to explore promising research in regenerative medicine using stem cells. The opening plenary session will feature an overview of hematopoietic stem cell therapy. This will be followed by four plenary sessions that will highlight cell-based therapies for the treatment of neurological, cardiac, musculoskeletal, and metabolic diseases and disorders. It will close with a presentation on induced pluripotent stem cells (iPSCs) and the issues that need to be addressed to enable their potential use in cell-based therapies.

Why: The purpose of the symposium is to determine productive new directions for research in regenerative medicine and to help NIH prioritize research with the greatest potential for clinical benefit.

Who: Speakers include:
Story C. Landis, Ph.D., National Institute of Neurological Disorders and Stroke, National Institutes of Health
James F. Battey, Jr., M.D., Ph.D., National Institute on Deafness and Other Communication Disorders, National Institutes of Health
Paolo Bianco, M.D., Sapienza Universita' di Roma
George Daley, M.D., Ph.D., Harvard Stem Cell Institute
Mark S. Freedman, M.D., M.Sc., University of Ottawa
Linda Griffith, Ph.D., Massachusetts Institute of Technology
Markus Grompe, M.D., Oregon Health & Science University
Douglas Kerr, M.D., Ph.D., Johns Hopkins University
Michael A. Laflamme, M.D., Ph.D., University of Washington
Annarosa Leri, M.D., Harvard Medical School
Douglas W. Losordo, M.D., Northwestern University
Stuart H. Orkin, M.D., Harvard Stem Cell Institute
Terence A. Partridge, Ph.D., Childrens National Medical Center
Darwin Prockop, M.D., Ph.D., Tulane University Medical School
Clive N. Svendsen, Ph.D., University of Wisconsin-Madison
Kenneth Zaret, Ph.D., Fox Chase Cancer Center

When: Tuesday, May 6, 2008, 8 a.m. to 5: 30 p.m.

Where: Natcher Conference Center, NIH Campus

Press Registration: For a registration form please send your name and email to nihsymposium@masimax.com, or call 866-710-0135 and leave your name and phone number. To be admitted into the symposium, you will need to show your press ID (or credentials) at the registration desk to receive a name badge.


'/>"/>

Contact: Marian Emr
301-496-5924
NIH/National Institute of Neurological Disorders and Stroke
Source:Eurekalert

Related biology news :

1. Challenges remain in reintroducing American chestnut
2. Choices and Challenges forum to address nuclear power issue
3. Triage study challenges notions of emergency medical response to disaster
4. Weird water: Discovery challenges long-held beliefs about waters special properties
5. Innovative civil engineering application promises cleaner waters
6. New CPR promises better results by compressing abdomen, not Chest
7. Tiny tubes and rods show promise as catalysts, sunscreen
8. New genetic research into nicotine addiction shows promise for personalized treatment
9. Genetic ancestral testing cannot deliver on its promise, study warns
10. Sweet potato shines as new promise for small enterprise and hunger relief in developing countries
11. Summer-dormant tall fescue grass shows promise for pasture improvements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... , June 23, 2016 On ... session at 4,833.32, down 0.22%; the Dow Jones Industrial Average ... 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez ... Inc. (NASDAQ: BIND ). Learn more about these ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, a division of ... and optimized exclusively for Okuma CNC machining centers at The International Manufacturing Technology ... among several companies with expertise in toolholding, cutting tools, machining dynamics and distribution, ...
(Date:6/22/2016)... June 22, 2016 Cell Applications, Inc. ... them to produce up to one billion human ... within one week. These high-quality, consistent stem cells ... cells and spend more time doing meaningful, relevant ... proprietary, high-volume manufacturing process that produces affordable, reliable ...
Breaking Biology Technology: